Skip to main content
. 2020 Nov 23;19(23):3260–3276. doi: 10.1080/15384101.2020.1839697

Table 3.

Association between miR-877 expression and clinical stages, differentiation degree and lymph node metastasis of LC patients

Clinical data
N
miR-877 expression in LC tissues
P value
    Low expression (n = 40) High expression (n = 40)  
Age (years)       0.823
≤ 65 38 18 (45.5) 20 (50.0)  
> 65 42 22 (54.5) 20 (40.0)  
Gender       0.622
Male 57 30 (75.0) 27 (67.5)  
Female 23 10 (25.0) 13 (32.5)  
Tumor diameter (cm)       0.999
≤ 3 33 17 (42.5) 16 (40.0)  
> 3 47 23 (57.5) 24 (60.0)  
Clinical stage       0.012
I + II 34 23 (57.5) 11 (27.5)  
III + IV 46 17 (42.5) 29 (72.5)  
Lymph node metastasis       < 0.001
No 48 13 (32.5) 32 (87.5)  
Yes 32 27 (67.5) 8 (12.5)  
Differentiation       < 0.001
Poor + moderate 52 36 (90.0) 16 (40.0)  
High 28 4 (10.0) 24 (60.0)  

miR-877, microRNA-877; LC, lung cancer.